BATM Advanced Communications Ltd - Israel-based networking and medical technology company - says it has developed a new test for the rapid and comprehensive diagnosis of tuberculosis. Test takes two hours instead of several days with current methods. Clinical trials to start in second half of this year, fully funded by UN's Stop TB Partnership. Expects sales to begin next year.
Current stock price: 98.40 pence
Year-to-date change: up 5.8%
By Ivan Edwards; ivanedwards@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.


(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately repor...


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:


LONDON (Alliance News) - BATM Advanced Communications Ltd Monday said it has won two contracts to provide its telecommunications technology to US serv...


LONDON (Alliance News) - BATM Advanced Communications Ltd said Monday that it had won a USD800,000 contract from Islington Council to provide surveill...


LONDON (Alliance News) - BATM Advanced Communications Ltd Tuesday said its first-quarter revenue, gross profit and operating profit were all slightly ...


LONDON (Alliance News) - BATM Advanced Communications Ltd said Thursday that it had won a diagnostics contract with the Ministry of Health in Latin Am...